Search

Your search keyword '"Parkhomenko, A. A."' showing total 312 results

Search Constraints

Start Over You searched for: Author "Parkhomenko, A. A." Remove constraint Author: "Parkhomenko, A. A." Publication Type Magazines Remove constraint Publication Type: Magazines
312 results on '"Parkhomenko, A. A."'

Search Results

1. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

3. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial

4. Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study

5. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

6. Forecasting demand and consumer behaviour on the car market (case of Ukraine and Slovakia)

7. Characteristics of HIF-1Α and HSP70 MRNA Expression, Level, and Interleukins in Experimental Chronic Generalized Periodontitis

8. MSM Solar-Blind Ultraviolet Detector Incorporating Asymmetric Contact Electrodes Fabricated on AlₓGa₁–ₓN Hetero-Epilayers

9. Title to Territory in Europe in the Context of the Russian-Ukrainian Armed Conflict: Methods, Illegal Claims and Legal Assessments

10. Pentafluorophenyl vinyl ketone: Synthesis, radical polymerization, copolymerization, and polymer degradation under ultra‐violetirradiation

12. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

13. Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial

17. International courts.

18. Propagation of Microwaves in Composites Containing Ultralong Carbon Nanotubes

19. Ultra-Sensitive Magnetoelectric Sensors of Magnetic Fields for Biomedical Applications

23. SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021

25. Information integration efficiency in ports and port stations transport service

26. Extra-transport effect in quality management of transport companies

27. The algorithm of organizational and technical environmental decisions development in transport organizations

28. The cost mechanism digital transformation in international freight transportation

29. The economic efficiency justification of multimodal container transportation

30. Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial

31. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study

32. Ertugliflozin and Slope of Chronic eGFR

33. Neutron Diffraction Characterization of the Microstrain Fields in the Dilute ZnSe:Co Magnetic Semiconductor Crystals

34. Application of Nanotechnologies in Studying Yeast Structure in Candida

35. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

36. Phase Composition and Thermoelectric Properties of Materials Based on Cu2 –xSe (0.03 ≤ x≤ 0.23)

37. Effect of starting materials and sintering temperature on microstructure and optical properties of Y2O3:Yb3+5 at% transparent ceramics

38. Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial

39. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

40. Preparation and Characterization of a Flexible rGO–PTFE Film for a Supercapacitor Current Collector

41. Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease

42. Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin

43. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

44. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

45. Ionic Liquid-Assisted Strategy for Morphology Engineering of Inorganic Cesium-Based Perovskite Thin Films Toward High-Performance Solar Cells

46. Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial

47. Thin Films of Unsubstituted and Fluorinated Palladium Phthalocyanines: Structure and Sensor Response toward Ammonia and Hydrogen

48. Blog talk

49. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

50. Effect of Alirocumab on Mortality After Acute Coronary Syndromes

Catalog

Books, media, physical & digital resources